Only for ET, the IPSET-thrombosis system that includes age, previous thrombosis, cardiovascular risk factors, and JAK2-V617F mutation is the recommended prognostic system and it should be scored in all patients at diagnosis. Here, JAK2 is linked to essential thrombocythemia.